Skip to main content

Investors

Il Gruppo Ulisse Biomed è un gruppo biotech integrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.

Investors

Il Gruppo Ulisse Biomed è un gruppo biotech intyegrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.

27 Giugno, 2022

Notizie e aggiornamenti

Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich


Hyris presented its Hyris System™ and the new T Cells test in Munich last week, at Analytica 2022, the world largest laboratory technology fair.

At booth A3.115, Hyris team met new potential partners, clients and investors.

It was also a good chance for updating some market context and look at competitors products and releases.

Hyris System™ proved to be of interest for many players, with its disruptive approach to democratic genetics. Moreover, the newly launched innovative approach for T cells response measurement to SARS-CoV-2 has been appreciated by many practitioners.

The participation to Analytica 2022 confirmed Hyris committment to confront with market needs and dynamics, as well to offer customers and partners disruptive solutions, leveraging Hyris signature technology.